Role of Inflammation in Initiation and Perpetuation of Atrial Fibrillation

This publication has 64 references indexed in Scilit:

• High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion
  International Journal of Cardiology, 2006
• Effects of statins beyond lipid lowering: Potential for clinical benefits
  International Journal of Cardiology, 2006
• Effects of C-Reactive Protein and the Third and Fourth Components of Complement (C3 and C4) on Incidence of Atrial Fibrillation
  The American Journal of Cardiology, 2006
• Effect of C-reactive protein reduction on paroxysmal atrial fibrillation
  American Heart Journal, 2005
• Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: Results from the Valsartan Heart Failure Trial (Val-HeFT)
  American Heart Journal, 2005
• The Role of Angiotensin Receptor Blockers and/or Angiotensin Converting Enzyme Inhibitors in the Prevention of Atrial Fibrillation in Patients with Cardiovascular Diseases:
  Pacing and Clinical Electrophysiology, 2004
• Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation
  American Heart Journal, 2004
• Relation of interleukin-6, C-reactive protein, and the prothrombotic state to transesophageal echocardiographic findings in atrial fibrillation
  The American Journal of Cardiology, 2004
• Angiotensin-converting enzyme inhibitors as adjunctive therapy in patients with persistent atrial fibrillation
  American Heart Journal, 2004
• Acute-Phase Proteins and Other Systemic Responses to Inflammation
  New England Journal of Medicine, 1999